Welcome to Novo Nordisk in the United States
  • Welcome to
    Novo Nordisk
    in the U.S.

    As the world's leading diabetes care company, we believe that to do what is good for the patient, we must do what is good for the world.

    Learn more about
    Novo Nordisk
    in the U.S.
  • Cities Changing Diabetes

    By 2035, nearly half a billion people will have diabetes, nearly all of them in cities.1 Join us in the global fight against #urbandiabetes.

    Learn more
  • Novo Nordisk
    Diabetes Education Program

    NCQA has reviewed and
    certified Novo Nordisk, Inc.'s
    Diabetes Education Program
    Design capability.

    Learn More
  • Novo Nordisk Annual Report 2014

    Read about our financial, social and environmental performance

    See how it all adds up

Featured news

Novo Nordisk Diabetes Education Program

NCQA has reviewed and certified Novo Nordisk Inc.’s Diabetes Education Program Design capability.

Learn More

Products

Learn about our protein-based medicines for: Diabetes
Hemophilia and other medical conditions

Latest news

Company Announcement: Novo Nordisk increased operating profit in local currencies by 13% in 2014
Jan 30, 2015

Novo Nordisk Receives FDA Approval for Norditropin® FlexPro® 30 mg/3.0 mL for Patients with Growth Hormone Disorders
Jan 26, 2015

More News

Join our team

Explore our open positions
Please select